Organogenesis Holdings (ORGO) Other Non-Current Assets (2017 - 2026)

Organogenesis Holdings' (ORGO) quarterly Other Non-Current Assets came in at $16.1 million in Q1 2026, up 176.47% year-on-year from $5.8 million in Q1 2025, and up 75.26% quarter-over-quarter from $9.2 million in Q4 2025.

Organogenesis Holdings (ORGO) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Organogenesis Holdings' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $16.1 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 176.47% year-over-year to $16.1 million in Q1 2026; TTM through Mar 2026 was $16.1 million, a 176.47% increase from a year earlier, with the FY2025 full-year figure at $9.2 million, up 83.88% from the prior year.
  • Other Non-Current Assets advanced to $16.1 million in Q1 2026 per ORGO's latest filing, from $9.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $16.1 million in Q1 2026 and bottomed at $1.3 million in Q3 2023.
  • The 5-year median for Other Non-Current Assets is $5.0 million (2024), against an average of $5.5 million.
  • Across the five-year window, Other Non-Current Assets fell 16.87% in 2023 and surged 358.58% in 2024, its largest moves.
  • Year by year, Other Non-Current Assets stood at $1.5 million in 2022, then soared by 294.08% to $6.0 million in 2023, then declined by 16.44% to $5.0 million in 2024, then soared by 83.88% to $9.2 million in 2025, then jumped by 75.26% to $16.1 million in 2026.
  • Per Business Quant, the three latest ORGO Other Non-Current Assets figures stand at $16.1 million (Q1 2026), $9.2 million (Q4 2025), and $14.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Organogenesis Holdings 310.55 Mn 218.45 Mn 11.46 Mn 16.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.13 Mn
Dec 31, 2025 9.20 Mn
Sep 30, 2025 14.41 Mn
Jun 30, 2025 8.73 Mn
Mar 31, 2025 5.83 Mn
Dec 31, 2024 5.01 Mn
Sep 30, 2024 5.01 Mn
Jun 30, 2024 5.85 Mn
Mar 31, 2024 6.71 Mn
Dec 31, 2023 5.99 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.39 Mn
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.52 Mn
Sep 30, 2022 1.59 Mn
Jun 30, 2022 1.67 Mn
Mar 31, 2022 1.47 Mn
Dec 31, 2021 1.54 Mn
Sep 30, 2021 1.61 Mn
Jun 30, 2021 605,000.00